The diagnostic role of albumin-based ratio markers for periprosthetic joint infection

Panlong Fan1, Qianqian Cao1, Liya Sun2

  • 1Department of Orthopaedics, Zhengzhou University People's Hospital, Henan Provincial People's Hospital, Zhengzhou, Henan, China.

Abstract

Insights

New albumin (ALB) ratio biomarkers show promise for diagnosing periprosthetic joint infection (PJI). The CRP/ALB ratio (CAR) and composite index CAR + EAR (CEAR) demonstrated high accuracy, aiding in PJI diagnosis.

Area of Science:

  • Orthopedics
  • Infectious Diseases
  • Biochemistry

Background:

  • Periprosthetic joint infection (PJI) is a severe complication of total joint arthroplasty.
  • Accurate PJI diagnosis is critical but challenging, as single biomarkers are often insufficient.
  • Albumin (ALB) ratio-based inflammatory marker combinations are underexplored for PJI diagnosis.

Purpose of the Study:

  • To investigate the diagnostic efficacy of novel biomarkers based on albumin ratios for PJI.
  • To evaluate the performance of CRP/ALB ratio (CAR), ESR/ALB ratio (EAR), and CEAR in differentiating PJI from aseptic loosening (AL).

Main Methods:

  • Retrospective analysis of 257 PJI patients and 137 AL patients.
  • Comparison of serum levels of CRP, ESR, ALB, CAR, EAR, and CEAR.
  • Diagnostic performance assessed using ROC curves and AUC.

Main Results:

  • PJI patients had significantly higher CRP, ESR, CAR, EAR, and CEAR levels, and lower serum ALB compared to AL patients.
  • Novel markers CAR, EAR, and CEAR demonstrated high diagnostic accuracy.
  • CAR (AUC=0.929) and CEAR (AUC=0.917) showed superior performance compared to EAR (AUC=0.890).

Conclusions:

  • Albumin ratio-based markers are promising adjunctive diagnostic tools for PJI.
  • CEAR diagnostic efficacy is comparable to CAR, both outperforming EAR.
  • These novel biomarkers can improve PJI diagnosis accuracy.